Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Apogee Therapeutics
APGE
$10.2B
| $10.6M | ﹤0.01% |
140,727
-289,736
| -67% | -$18.2M |
|
2127
CALL
Abercrombie & Fitch
ANF
$6.48B
| $10.6M | ﹤0.01% |
84,300
+35,000
| +71% | +$3.06M |
|
2128
Structure Therapeutics
GPCR
$3.51B
| $10.6M | ﹤0.01% |
152,560
-1,121,991
| -88% | -$45.8M |
|
2129
Trupanion
TRUP
$1.3B
| $10.6M | ﹤0.01% |
283,746
-335,257
| -54% | -$13.2M |
|
|
BBUC
2130
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.73B
| $10.6M | ﹤0.01% |
295,351
+227,555
| +336% | +$7.97M |
|
2131
MoonLake Immunotherapeutics
MLTX
$1.32B
| $10.6M | ﹤0.01% |
802,722
+713,550
| +800% | +$8.42M |
|
2132
Teladoc Health
TDOC
$1.16B
| $10.6M | ﹤0.01% |
1,510,686
+1,212,564
| +407% | +$9.49M |
|
2133
Enanta Pharmaceuticals
ENTA
$402M
| $10.6M | ﹤0.01% |
670,428
-277,656
| -29% | -$3.53M |
|
2134
Lionsgate Studios
LION
$3.43B
| $10.5M | ﹤0.01% |
1,154,547
-476,130
| -29% | -$3.39M |
|
2135
PUT
MetLife
MET
$61.2B
| $10.5M | ﹤0.01% |
133,500
-18,600
| -12% | -$1.47M |
|
2136
Bit Digital
BTBT
$573M
| $10.5M | ﹤0.01% |
5,575,498
-1,493,505
| -21% | -$4.32M |
|
2137
Ingredion
INGR
$6.53B
| $10.5M | ﹤0.01% |
95,255
-119,953
| -56% | -$13.5M |
|
2138
Blue Bird Corp
BLBD
$1.9B
| $10.5M | ﹤0.01% |
223,449
+24,881
| +13% | +$1.3M |
|
2139
CALL
Toyota
TM
$227B
| $10.5M | ﹤0.01% |
49,000
-33,000
| -40% | -$6.69M |
|
2140
TAL Education Group
TAL
$6.5B
| $10.5M | ﹤0.01% |
960,977
+849,711
| +764% | +$9.65M |
|
2141
Choice Hotels
CHH
$4.89B
| $10.5M | ﹤0.01% |
110,040
+83,142
| +309% | +$7.91M |
|
2142
Axcelis
ACLS
$3.78B
| $10.5M | ﹤0.01% |
130,090
-131,686
| -50% | -$11M |
|
2143
Brookfield Infrastructure
BIPC
$4.84B
| $10.4M | ﹤0.01% |
229,857
+65,271
| +40% | +$2.96M |
|
2144
STAAR Surgical
STAA
$1.12B
| $10.4M | ﹤0.01% |
451,291
+334,272
| +286% | +$8.62M |
|
2145
PUT
Elevance Health
ELV
$86.6B
| $10.4M | ﹤0.01% |
29,700
+11,300
| +61% | +$3.82M |
|
2146
CALL
Stryker
SYK
$124B
| $10.4M | ﹤0.01% |
29,600
-2,300
| -7% | -$838K |
|
2147
Franklin Electric
FELE
$4.52B
| $10.4M | ﹤0.01% |
108,794
+13,049
| +14% | +$1.25M |
|
2148
Vitamin Cottage Natural Grocers
NGVC
$628M
| $10.4M | ﹤0.01% |
414,716
-124,647
| -23% | -$3.99M |
|
2149
Brink's
BCO
$4.51B
| $10.4M | ﹤0.01% |
88,992
-116,373
| -57% | -$13.3M |
|
2150
Portillo's
PTLO
$325M
| $10.4M | ﹤0.01% |
+2,279,826
| New | +$11.9M |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.